Evidence map›Paper›PMID 33204070›Full record

ArticleDrug design, development and therapy2020

Downregulation of miR-200a Protects Mouse Leydig Cells Against Triptolide by Triggering Autophagy.

Hui Miao, Congxiu Miao, Jing Han, Na Li

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hui MiaoDepartment of Reproduction and Genetics, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, People's Republic of China.
Congxiu MiaoDepartment of Reproduction and Genetics, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, People's Republic of China.
Jing HanDepartment of Reproduction and Genetics, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, People's Republic of China.
Na LiDepartment of Reproduction and Genetics, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, People's Republic of China.
Changzhi Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroRNAs play important roles in testicular development and spermatogenesis. Previous research has indicated that the level of miR-200a was significantly upregulated in patients with different spermatogenic impairments. However, the mechanism by which miR-200a regulated spermatogenic impairments remains unclear.

methodsLeydig cells were treated with triptolide (TP) to mimic spermatogenic impairments. CCK-8 and flow cytometry were used to detect the proliferation and apoptosis in Leydig cells, respectively. In addition, Western blot assay was used to examine ATG7, ATG5, p62 protein levels in MLTC-1 cells.

resultsTP dose-dependently upregulated the expression of miR-200a in MLTC-1 cells. In addition, TP inhibited the proliferation of MLTC-1 cells via inducing apoptosis and oxidative stress; however, these phenomena were notably reversed by miR-200a antagomir. Furthermore, luciferase reporter assay identified that ATG7 was the direct binding target of miR-200a. TP treatment markedly inhibited the activation of autophagy in MLTC-1 cells via inhibition of ATG7. Conversely, downregulation of miR-200a significantly induced autophagy in TP-treated MLTC-1 cells by activation of ATG7. Meanwhile, the cell protective effects of miR-200a against TP were reversed by autophagy inhibitor 3MA, indicating that autophagy plays an important role.

conclusionThese results indicated that downregulation of miR-200a could protect MLTC-1 cells against TP by inducing autophagy. Therefore, miR-200a might serve as a new therapeutic target for the treatment of male hypogonadism.

Indexed as

Down-RegulationAnimalsAutophagyCells, CulturedDiterpenesDose-Response Relationship, DrugEpoxy CompoundsLeydig CellsMaleMiceMicroRNAsMolecular ConformationPhenanthrenesReactive Oxygen SpeciesDiterpenesEpoxy CompoundsMicroRNAsMirn200 microRNA, mousePhenanthrenesReactive Oxygen SpeciestriptolideapoptosisautophagyhypogonadismmicroRNA-200atriptolide

Identifiers

PMID33204070
PMCPMC7667511
OpenAlexW3103120244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.